Accelerating the Discovery, Development & Approval of First-In-Class Selective, Safe & Efficacious Degraders & Proximity-Based Drugs to Target the Undruggable
As the TPD field eagerly awaits the approval of Arvinas’s Vepdegestrant, and with C4 Therapeutics and Kymera progressing through Phase 1 and 2 clinical trials, 2025 is poised to be the year of clinical validation for TPD. This has been echoed in the flurry of partnerships worth over $200M in 2025 alone, with the majority of big pharma now invested in molecular glues, PROTACs, or novel induced proximity drugs.
Returning as the industry’s definitive forum from early discovery to clinical development, the 8th Annual TPD & Induced Proximity Summit is the world’s largest and longest-standing forum for proximity-based modalities, enabling you to fully immerse yourself in the breadth and depth of cutting-edge induced proximity therapeutic development.
Featuring key leaders such as Arvinas, Nurix Therapeutics, C4 Therapeutics, and innovative newcomers including Larkspur Bio, Magnet Biomedicine, TrimTech Therapeutics, as well as the co-founders of TPD, Craig Crews and Ray Deshaies, this is your ultimate meeting to hear the latest clinical data, forge strategic relationships, and capitalize on the huge opportunity for this modality to treat patients with high unmet clinical need.
In the rapidly advancing field of TPD research, this summit is an excellent opportunity to see a number of amazing cutting-edge approaches from academia, biotech and pharma.
Kazuteru Aoki, Vice President of Biology, FIMECS, Inc.
In a rapidly evolving drug development landscape, engaging with global experts at the TPD Summit is not just an opportunity—it’s a strategic imperative to validate and sharpen the competitive edge of our protein degrader platform.
Hyunson Jo, Founder and CEO, Pin Therapeutics
The TPD&IP Summit is THE meeting each year to learn from the best and brightest minds working on PROTACs, DACs, and molecular glues -- it is THE not-miss meeting to stay on top of this rapidly evolving field.
Brent Meadows, CBO, Polymed Bio
Explore the Full Event Guide
- 80+ World Class Speakers
- 4 Days of Exclusive Data-Driven TPD Content
- CXO and VC Panel Discussions
- Bespoke Networking & Partnering Opportunities
- The World’s Leading Event for the TPD & Induced Proximity Industry
Accommodation
Limited Rooms
Please note: As there is a Citywide taking place at the same time as the TPD Summit, our conference venue the Westin Boston Seaport District is fully booked during this period.
However, we are excited to announce that we have secured 2 room blocks in the Seaport area exclusively for attendees to secure discounted rates. We have limited availability and expect these to fill quickly, so we recommend to book as soon as possible.
Please see links below to book:
Announcing the Crews & Deshaies Award for the Induced Proximity Innovator of the Year
Get ready for the best TPD & Induced Proximity Summit to date—featuring the field’s original pioneers, Craig Crews and Ray Deshaies. Join us to hear their insights on where induced proximity is headed, the latest developments from the Crews lab, and celebrate the launch of the first-ever “Crews & Deshaies Award for the Induced Proximity Innovator of the Year” at the Annual TPD & Induced Proximity Awards. With Arvinas’s recent NDA submission marking what could be the first FDA-approved PROTAC, alongside exciting clinical advances from other leading players, 2025 is shaping up to be a landmark year for the field. There’s no better time to learn from the trailblazers who started it all.
Official Partners
Expertise Partner
Program Partners
Attending Companies Include
Explore the Agenda
Hear the latest industry breakthroughs and gain exclusive insights on the TPD innovations during our packed agenda, interactive roundtables, and new CCOs & VC panel discussions.
Partner With Us
Position yourself alongside as the leading solution provider to ensure your brand is at the heart of TPD biopharma deals.
Join Biopharma Experts
Be part of the hottest conversations with like-minded attendees spanning all stages of drug development and make critical connections during our dedicated networking sessions.